Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123942) titled 'A Randomized, Open-label, Controlled Clinical Study on Eradication of Helicobacter pylori: Dual Therapy with Tegoprazan Combined with Amoxicillin or Doxycycline versus Bismuth-containing Quadruple Therapy' on May 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shenzhen Nanshan People's Hospital
Condition:
Helicobacter pylori infection
Intervention:
Group B (Novel TD Dual Therapy):Tegoprazan 50 mg twice daily + Doxycycline 100 mg twice daily for 14 days.
Group A (High-dose TA Dual Therapy):Tegoprazan 50 mg twice daily + Amoxicillin 1.0 g three times daily for 14 days.
Recruitment ...